Antianginal Drugs_ Medicinal Chemistry

Antianginal Drugs: Medicinal Chemistry

Antianginal drugs encompass several classes of compounds, each with distinct chemical structures and properties. This overview will focus on the medicinal chemistry aspects of the major classes of antianginal drugs, including nitrates, beta-blockers, calcium channel blockers, and ranolazine.

Nitrates:

Nitrates are organic esters of nitric acid. The most common nitrates used in angina treatment are:

a) Nitroglycerin (Glyceryl trinitrate):

Chemical formula: C3H5N3O9

Structure: A triol with three nitrate ester groups

b) Isosorbide dinitrate:

Chemical formula: C6H8N2O8

Structure: A bicyclic compound with two nitrate ester groups

c) Isosorbide mononitrate:

Chemical formula: C6H9NO6

Structure: Similar to isosorbide dinitrate but with only one nitrate ester group

The nitrate groups in these molecules are responsible for their vasodilatory effects. In vivo, these compounds release nitric oxide (NO), which activates guanylate cyclase, leading to smooth muscle relaxation.

<ol start=”2”>

Beta-blockers:

Beta-blockers are a diverse group of compounds that share the ability to block beta-adrenergic receptors. They typically contain:

An aromatic ring

An alkyl substituent

A secondary or tertiary amine group

Examples include:

a) Propranolol:

Chemical formula: C16H21NO2

Structure: Contains a naphthalen-1-yloxy group and a propan-2-ylamino side chain

b) Metoprolol:

Chemical formula: C15H25NO3

Structure: Contains a para-substituted phenoxy group and a methoxyethyl side chain

The aromatic ring in these compounds interacts with the receptor's binding pocket, while the amine group forms hydrogen bonds with specific amino acid residues.

<ol start=”3”>

Calcium Channel Blockers (CCBs):

CCBs are chemically diverse but can be broadly classified into two groups:

a) Dihydropyridines (e.g., Amlodipine):

Chemical formula: C20H25ClN2O5

Structure: Contains a 1,4-dihydropyridine ring with ester groups at positions 3 and 5

b) Non-dihydropyridines:

Verapamil: Contains a phenylalkylamine structure

Diltiazem: Contains a benzothiazepine ring

The basic nitrogen in these compounds is crucial for their calcium channel blocking activity. The aromatic rings contribute to lipophilicity and membrane penetration.

<ol start=”4”>

Ranolazine:

Chemical formula: C24H33N3O4

Structure: Contains a piperazine ring and a phenyl ring connected by an alkyl chain

Ranolazine's structure allows it to interact with the late sodium channels in cardiac cells, inhibiting the late sodium current.

Structure-Activity Relationships (SAR):

Nitrates: The number and position of nitrate groups affect the drug's potency and duration of action. Compounds with more nitrate groups (like nitroglycerin) act more rapidly but have shorter durations of action.

Beta-blockers: The nature of the aroent and the alkyl side chain influences receptor selectivity (尾1 vs. 尾2) and lipophilicity, affecting the drug's pharmacokinetics and tissue distribution.

CCBs: For dihydropyridines, modifications to the substituents on the 1,4-dihydropyridine ring can alter potency, tissue selectivity, and pharmacokinetics. The stereochemistry of these compounds is also crucial for their activity.

Ranolazine: The piperazine ring and the alkyl chain length are essential for its unique mechanism of action.

In drug development, medicinal chemists often modify these basic structures to improve efficacy, reduce side effects, or enhance pharmacokinetic properties. This process involves careful consideration of the structure-activity relationships, aiming to optimize the balance between the desired therapeutic effects and potential drawbacks of each compound.